These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8750377)

  • 1. Financial effect of clinical decisions: case study of a dialysis center.
    Balas EA; Hicks LL; Stone JV; Ponferrada LP; West DA
    J Med Syst; 1995 Dec; 19(6):465-74. PubMed ID: 8750377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of capitation on free-standing dialysis facilities: can you survive?
    McMurray SD; Miller J
    Am J Kidney Dis; 1997 Oct; 30(4):542-8. PubMed ID: 9328370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of inpatient and outpatient Medicare allowable charges for continuous ambulatory peritoneal and center hemodialysis patients: a single-center study.
    Prowant BF; Kappel DF; Campbell A
    Am J Kidney Dis; 1986 Oct; 8(4):248-52. PubMed ID: 3532772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis.
    Cortés-Sanabria L; Paredes-Ceseña CA; Herrera-Llamas RM; Cruz-Bueno Y; Soto-Molina H; Pazarín L; Cortés M; Martínez-Ramírez HR
    Arch Med Res; 2013 Nov; 44(8):655-61. PubMed ID: 24211750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of dialysis modalities in Italy.
    Tediosi F; Bertolini G; Parazzini F; Mecca G; Garattini L
    Health Serv Manage Res; 2001 Feb; 14(1):9-17. PubMed ID: 11246787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing a peritoneal dialysis program's cost by changing from a vendor-provided to a program-provided system for general medical supplies: significant savings in CCPD.
    Holley JL; McGuirl K; Smith S; Caswell N
    Am J Kidney Dis; 1998 Apr; 31(4):662-5. PubMed ID: 9531183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.
    Hirth RA; Held PJ; Orzol SM; Dor A
    Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of home assistance for peritoneal dialysis: results of a European survey.
    Dratwa M
    Kidney Int Suppl; 2008 Apr; (108):S72-5. PubMed ID: 18379552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates.
    Fenton SS; Schaubel DE; Desmeules M; Morrison HI; Mao Y; Copleston P; Jeffery JR; Kjellstrand CM
    Am J Kidney Dis; 1997 Sep; 30(3):334-42. PubMed ID: 9292560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.
    Coyte PC; Young LG; Tipper BL; Mitchell VM; Stoffman PR; Willumsen J; Geary DF
    Am J Kidney Dis; 1996 Apr; 27(4):557-65. PubMed ID: 8678067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous peritoneal dialysis for children: a decade of worldwide growth and development.
    Alexander SR; Honda M
    Kidney Int Suppl; 1993 Feb; 40():S65-74. PubMed ID: 8445841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rehabilitation in patients undergoing home dialysis. Continuous ambulatory or cyclic peritoneal dialysis vs home hemodialysis.
    Rubin J; Case G; Bower J
    Arch Intern Med; 1990 Jul; 150(7):1429-31. PubMed ID: 2369241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance in CAPD and CCPD patients as measured by supply inventories during home visits.
    Bernardini J; Piraino B
    Am J Kidney Dis; 1998 Jan; 31(1):101-7. PubMed ID: 9428459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Gao H; Lew SQ; Bosch JP
    Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risks of peritoneal dialysis and hemodialysis.
    Collins AJ; Hao W; Xia H; Ebben JP; Everson SE; Constantini EG; Ma JZ
    Am J Kidney Dis; 1999 Dec; 34(6):1065-74. PubMed ID: 10585316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.
    Liu FX; Treharne C; Arici M; Crowe L; Culleton B
    Value Health; 2015 Jan; 18(1):17-24. PubMed ID: 25595230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.